Alnylam Pharmaceuticals (ALNY) Q3 2013 Earnings

8AugConfirmed
Nov 12
Feb 13
May 13
Q3 2013
-1.43
-1.01
-0.58
-0.16

Details

Expected EPS
N/A
Actual EPS
-0.29
Surprise EPS
-0.29
Surprise Percent
+∞%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.29 per share for Q3 2013.

0 Comments

Share your thoughts